KIRSKE DAVID (Chief Financial Officer) sold 8.8% of their position (16.96K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $72.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/13/2026ACC: 0001501697-26-000049
Officer· Chief Financial Officer
Since Aug 2025
-16.96K
Net shares
Net seller
$72.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.96K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.96K
Price / share
$4.29
Trade value
$72.82K
% of position
8.8%
5/12/2026
193.25K→176.29K
Total
Net shares
−16.96K
Net value
-$72.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/12/2026 | S · Sale | −16.96K | $4.29 | $72.82K | 8.8% | 193.25K | 176.29K |
| Total | −16.96K | -$72.82K | ||||||
Derivative Transactions0
No derivative transactions reported